BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modi SJ, Kulkarni VM. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma. Eur J Med Chem 2020;207:112851. [PMID: 33002846 DOI: 10.1016/j.ejmech.2020.112851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01569-x] [Reference Citation Analysis]
2 Modi SJ, Kulkarni VM. Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, 'DFG-out' inhibitors. J Biomol Struct Dyn 2021;:1-16. [PMID: 33459187 DOI: 10.1080/07391102.2021.1872417] [Reference Citation Analysis]
3 Girgis AS, Panda SS, Srour AM, Abdelnaser A, Nasr S, Moatasim Y, Kutkat O, El Taweel A, Kandeil A, Mostafa A, Ali MA, Fawzy NG, Bekheit MS, Shalaby EM, Gigli L, Fayad W, Soliman AAF. 3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2. Bioorg Chem 2021;114:105131. [PMID: 34243074 DOI: 10.1016/j.bioorg.2021.105131] [Reference Citation Analysis]
4 Hassan A, Badr M, Abdelhamid D, Hassan HA, Abourehab MA, Abuo‐rahma GEA. Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold. Bioorganic Chemistry 2022;120:105631. [DOI: 10.1016/j.bioorg.2022.105631] [Reference Citation Analysis]
5 Guo J, Guo M, Zheng J. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway. Cancer Manag Res 2021;13:773-85. [PMID: 33536785 DOI: 10.2147/CMAR.S281969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang C, Liu S, Yang M. Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options. Front Endocrinol (Lausanne) 2021;12:808526. [PMID: 35002979 DOI: 10.3389/fendo.2021.808526] [Reference Citation Analysis]
7 Modh DH, Modi SJ, Deokar H, Yadav S, Kulkarni VM. Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines. J Biomol Struct Dyn 2022;:1-16. [PMID: 35318898 DOI: 10.1080/07391102.2022.2053206] [Reference Citation Analysis]